business development news from FierceBiotech
News
Report: GSK to fund venture firm, back start-ups
In Vivo is reporting that GlaxoSmithKline plans to set aside up to $500 million for a new venture fund that will support its internal R&D work as well as fund start-ups created from Read more...
GPC jettisons 38 workers in new round of layoffs
GPC Biotech's failure to get an FDA approval on satraplatin for cancer will cost the jobs of another Read more...
San Diego biotechs expanding ties to China
These days in biotechnology, if you're not already tied in some way to China, you're giving it some Read more...
Merck snares NovaCardia in $350M buyout
Merck has bolstered its cardiovascular pipeline with a deal to buy NovaCardia for $350 million in cash. For Merck, the acquisition marks another Read more...
Press Release: AstraZeneca's Fourth Quarter Results 2006 [Excerpt]
Press Release: AstraZeneca's Fourth Quarter Results 2006 [Excerpt]
Read more...Press Release: Pfizer To Acquire BioRexis Pharmaceutical
Press Release: Pfizer To Acquire BioRexis Pharmaceutical
Read more...C&L: Pritchard tapped to run KaloBios
KaloBios Pharmaceuticals has appointed David W. Pritchard as president and CEO. Most recently he held the position of chief business officer at Rinat Neuroscience.
Edward Jacobs will be appointed CEO and president of Insert Therapeutics on January 1, 2007.
Geron Corporation has appointed Alan B. …
Read more...DeCODE alleges ex-employees stole trade secrets
Iceland's deCODE Genetics is suing five former employees for allegedly stealing research knowledge and trade secrets and using them at Children's Hospital in Philadelphia. And the biotech company says the theft was done with the knowledge of the hospital staff, an allegation the hospital denies. Hakon Hakonarson, deCODE's former vice president of business development, is named in the suit along with four others recruited by the Center for Applied Genomics, which is part of Children's …
Read more...C&L: Gonda tapped to run Aradigm
Igor Gonda has been named president and CEO of Aradigm, replacing Bryan Lawlis, who also resigned from the board.
Impax Laboratories announced that CEO Barry Edwards resigned and will be replaced by President Larry Hsu on October 1.
Transport Pharmaceuticals announced that …
Read more...C&L: Brian M. Gallagher joins Magen Biosciences as CEO
Brian M. Gallagher has joined Magen Biosciences as president and CEO.
John F. DeBernardis will resign as CEO of Applied NeuroSolutions.
Neuren Pharmaceuticals announced the appointment of Parmjot Bains, MD to the position of COO.
Proteome Sciences has named Peter Schulz-Knappe, MD as Research and …
Read more...Paid Research Reports
- Drug Repositioning Strategies - Serendipity by design
- eHealthInsight Series: Online Patient Recruitment Strategies - Optimizing the clinical trial process
- Pricing & Reimbursement - Seven Major Markets Update
- Innovative Clinical Trial Design and Management: Trends, success stories and impact upon R&D budgets
- The Emerging Role of Postmarketing Clinical Research: Regulatory issues, strategic drivers and overall trends